GlassScriptPhysician profile
Marie Therese Sohner
NPI 1285630871
$8,232.53
in general payments reported to CMS, 2019-2025
34 companies · $21.81 in 2025
The $21.81 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $580 · 2020: $2,244 · 2021: $725 · 2022: $1,002 · 2023: $1,133 · 2024: $2,527 · 2025: $21.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,668 · Education: $1,013.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,668.38 |
| Education | $1,013.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,805.87 | 2019-2024 | |
| Merz North America, INC. | $680.54 | 2020-2021 | |
| Abbvie INC. | $475.01 | 2019-2024 | Lo Loestrin Fe |
| Pfizer INC. | $405.13 | 2021-2024 | |
| Evofem Biosciences, INC. | $397.76 | 2021-2024 | Phexxi |
| Astellas Pharma US INC | $337.28 | 2022-2024 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $320.18 | 2023-2024 | Myfembree |
| Myovant Sciences INC. | $301.15 | 2021-2022 | |
| Biogen, INC. | $272.54 | 2024 | Zurzuvae |
| Shield Therapeutics INC | $263.18 | 2023-2024 | Accrufer |
| Daiichi Sankyo INC. | $223.35 | 2021-2023 | Injectafer |
| Exeltis, USA INC. | $212.21 | 2021-2024 | Slynd |
| Mayne Pharma Commercial LLC | $184.66 | 2022-2023 | |
| Agile Therapeutics, INC. | $176.50 | 2021-2024 | Twirla |
| Millicent US INC | $148.25 | 2019-2024 | Intrarosa, Femring |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $123.41 | 2024 | Evenity |
| Therapeuticsmd, INC. | $98.44 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $92.25 | 2019-2023 | Gardasil 9 |
| Hologic Sales and Service, LLC | $88.93 | 2019-2024 | Aptima, Thinprep 2000 Processor |
| Avanos Medical | $86.47 | 2019-2024 | On-Q* Pump and Accessories |
| Bayer Healthcare Pharmaceuticals INC. | $84.50 | 2019-2023 | |
| Avion Pharmaceuticals | $81.16 | 2020-2023 | Balcoltra |
| Organon LLC | $56.65 | 2022-2024 | |
| Allergan, INC. | $53.65 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $44.06 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $39.83 | 2021-2022 | |
| Aspira Women'S Health INC | $36.47 | 2019-2024 | Ova1 |
| Coopersurgical, INC. | $32.58 | 2019-2021 | |
| Innovation Technologies INC | $24.14 | 2024 | Irrisept |
| Incyte Corporation | $21.81 | 2025 | Jakafi |
| Medinc of Texas | $20.45 | 2024 | |
| Radius Health, INC. | $18.40 | 2024 | Tymlos |
| Mission Pharmacal Company | $13.09 | 2021 | |
| Acessa Health INC. | $12.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marie Sohner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.